What Do the Terms that Describe a Clinical Trial Convey? von Dal-Ré, Rafael

Volltext

Current policies of non‐commercial funders towards transparency in clinical trials von Dal‐Ré, Rafael

Volltext

Voluntary transparency of sponsors of medicines clinical trials is exceptional von Dal-Ré, Rafael

Volltext

Waivers of informed consent in research with competent participants and the Declaration of Helsinki von Dal-Ré, Rafael

Volltext

Is “interventional trial” a correct term to use in clinical research? von Dal-Ré, Rafael

Volltext

COVID-19 drug research and the cohort multiple randomised controlled trial design von Dal-Ré, Rafael

Volltext

Off‐label prescription of BNT162b2 mRNA COVID‐19 vaccine to <5‐year‐old children in the European Union von Dal‐Ré, Rafael, Calvo, Cristina, Neth, Olaf

Volltext

On the semantics of clinical trials. The case of a ‘pragmatic’ trial in Alzheimer’s disease von Dal‐Ré, R.

Volltext

Will AstraZeneca be able to provide clinical trial data on its COVID‐19 vaccine efficacy in older adults? von Dal‐Ré, Rafael

Volltext

Clinical Equipoise in COVID‐19 Vaccine Candidate Trials von Dal‐Ré, Rafael

Volltext

Placebo-controlled trials with COVID-19 vaccines: participants first von Dal-Ré, Rafael

Volltext

Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic? von Dal-Ré, Rafael, Janiaud, Perrine, Ioannidis, John P A

Volltext

The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials von Dal-Ré, Rafael

Volltext

Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach von Dal-Ré, Rafael, Becker, Sören L, Bottieau, Emmanuel, Holm, Søren

Volltext

Is full transparency in clinical trials an achievable goal? von Dal-Ré, Rafael

Volltext

Placebo control group in COVID-19 vaccine trials: context and timing matters von Dal-Ré, Rafael

Volltext

Articles provided insufficient information to conduct an appropriate retrospective assessment of the pragmatic/explanatory features of medicine trials with the PRECIS-2 tool von Dal-Ré, Rafael

Volltext

Sharing of Individual Participant Clinical Trial Data: It is Time to Abandon the “Look the Other Way” Attitude von Dal-Ré, Rafael

Volltext

US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine von Dal-Ré, Rafael

Volltext

Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label von Dal-Ré, Rafael, Launay, Odile

Volltext